nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluconazole—ABCB1—Mitomycin—urinary bladder cancer	0.158	0.292	CbGbCtD
Fluconazole—CYP3A4—Thiotepa—urinary bladder cancer	0.0719	0.133	CbGbCtD
Fluconazole—CYP3A5—Etoposide—urinary bladder cancer	0.05	0.0922	CbGbCtD
Fluconazole—ABCB1—Gemcitabine—urinary bladder cancer	0.0456	0.084	CbGbCtD
Fluconazole—CYP2C9—Fluorouracil—urinary bladder cancer	0.0402	0.0741	CbGbCtD
Fluconazole—CYP2C9—Cisplatin—urinary bladder cancer	0.0341	0.0629	CbGbCtD
Fluconazole—ABCB1—Cisplatin—urinary bladder cancer	0.0331	0.0611	CbGbCtD
Fluconazole—ABCB1—Etoposide—urinary bladder cancer	0.0325	0.06	CbGbCtD
Fluconazole—ABCB1—Doxorubicin—urinary bladder cancer	0.0222	0.0409	CbGbCtD
Fluconazole—ABCB1—Methotrexate—urinary bladder cancer	0.0215	0.0396	CbGbCtD
Fluconazole—CYP3A4—Etoposide—urinary bladder cancer	0.0195	0.036	CbGbCtD
Fluconazole—CYP3A4—Doxorubicin—urinary bladder cancer	0.0133	0.0245	CbGbCtD
Fluconazole—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000316	0.000955	CcSEcCtD
Fluconazole—Vomiting—Thiotepa—urinary bladder cancer	0.000315	0.000952	CcSEcCtD
Fluconazole—Infestation NOS—Epirubicin—urinary bladder cancer	0.000313	0.000945	CcSEcCtD
Fluconazole—Infestation—Epirubicin—urinary bladder cancer	0.000313	0.000945	CcSEcCtD
Fluconazole—Rash—Thiotepa—urinary bladder cancer	0.000313	0.000944	CcSEcCtD
Fluconazole—Dermatitis—Thiotepa—urinary bladder cancer	0.000312	0.000943	CcSEcCtD
Fluconazole—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000312	0.000942	CcSEcCtD
Fluconazole—Headache—Thiotepa—urinary bladder cancer	0.000311	0.000938	CcSEcCtD
Fluconazole—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.00031	0.000937	CcSEcCtD
Fluconazole—Decreased appetite—Etoposide—urinary bladder cancer	0.00031	0.000935	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000307	0.000928	CcSEcCtD
Fluconazole—Body temperature increased—Cisplatin—urinary bladder cancer	0.000307	0.000928	CcSEcCtD
Fluconazole—Fatigue—Etoposide—urinary bladder cancer	0.000307	0.000927	CcSEcCtD
Fluconazole—Stomatitis—Epirubicin—urinary bladder cancer	0.000305	0.000921	CcSEcCtD
Fluconazole—Jaundice—Epirubicin—urinary bladder cancer	0.000305	0.000921	CcSEcCtD
Fluconazole—Pain—Etoposide—urinary bladder cancer	0.000304	0.000919	CcSEcCtD
Fluconazole—Constipation—Etoposide—urinary bladder cancer	0.000304	0.000919	CcSEcCtD
Fluconazole—Neutropenia—Doxorubicin—urinary bladder cancer	0.000304	0.000917	CcSEcCtD
Fluconazole—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000302	0.000912	CcSEcCtD
Fluconazole—Asthenia—Gemcitabine—urinary bladder cancer	0.000299	0.000903	CcSEcCtD
Fluconazole—Pharyngitis—Methotrexate—urinary bladder cancer	0.000298	0.0009	CcSEcCtD
Fluconazole—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000296	0.000895	CcSEcCtD
Fluconazole—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000296	0.000894	CcSEcCtD
Fluconazole—Pruritus—Gemcitabine—urinary bladder cancer	0.000295	0.000891	CcSEcCtD
Fluconazole—Nausea—Thiotepa—urinary bladder cancer	0.000294	0.000889	CcSEcCtD
Fluconazole—Urethral disorder—Methotrexate—urinary bladder cancer	0.000294	0.000889	CcSEcCtD
Fluconazole—Feeling abnormal—Etoposide—urinary bladder cancer	0.000293	0.000886	CcSEcCtD
Fluconazole—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000292	0.000882	CcSEcCtD
Fluconazole—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000291	0.000879	CcSEcCtD
Fluconazole—Pruritus—Fluorouracil—urinary bladder cancer	0.00029	0.000876	CcSEcCtD
Fluconazole—Infestation NOS—Doxorubicin—urinary bladder cancer	0.00029	0.000874	CcSEcCtD
Fluconazole—Infestation—Doxorubicin—urinary bladder cancer	0.00029	0.000874	CcSEcCtD
Fluconazole—Visual impairment—Methotrexate—urinary bladder cancer	0.000289	0.000874	CcSEcCtD
Fluconazole—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000287	0.000867	CcSEcCtD
Fluconazole—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000286	0.000865	CcSEcCtD
Fluconazole—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000285	0.000862	CcSEcCtD
Fluconazole—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000284	0.000857	CcSEcCtD
Fluconazole—Urticaria—Etoposide—urinary bladder cancer	0.000283	0.000854	CcSEcCtD
Fluconazole—Jaundice—Doxorubicin—urinary bladder cancer	0.000282	0.000852	CcSEcCtD
Fluconazole—Stomatitis—Doxorubicin—urinary bladder cancer	0.000282	0.000852	CcSEcCtD
Fluconazole—Abdominal pain—Etoposide—urinary bladder cancer	0.000281	0.00085	CcSEcCtD
Fluconazole—Body temperature increased—Etoposide—urinary bladder cancer	0.000281	0.00085	CcSEcCtD
Fluconazole—Eye disorder—Methotrexate—urinary bladder cancer	0.000281	0.000847	CcSEcCtD
Fluconazole—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000281	0.000847	CcSEcCtD
Fluconazole—Asthenia—Cisplatin—urinary bladder cancer	0.000279	0.000842	CcSEcCtD
Fluconazole—Pharyngitis—Epirubicin—urinary bladder cancer	0.000279	0.000842	CcSEcCtD
Fluconazole—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000279	0.000841	CcSEcCtD
Fluconazole—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000277	0.000838	CcSEcCtD
Fluconazole—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000276	0.000834	CcSEcCtD
Fluconazole—Urethral disorder—Epirubicin—urinary bladder cancer	0.000275	0.000832	CcSEcCtD
Fluconazole—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000274	0.000827	CcSEcCtD
Fluconazole—Angiopathy—Methotrexate—urinary bladder cancer	0.000272	0.000822	CcSEcCtD
Fluconazole—Immune system disorder—Methotrexate—urinary bladder cancer	0.000271	0.000819	CcSEcCtD
Fluconazole—Dizziness—Fluorouracil—urinary bladder cancer	0.000271	0.000819	CcSEcCtD
Fluconazole—Visual impairment—Epirubicin—urinary bladder cancer	0.000271	0.000818	CcSEcCtD
Fluconazole—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000271	0.000817	CcSEcCtD
Fluconazole—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00027	0.000816	CcSEcCtD
Fluconazole—Chills—Methotrexate—urinary bladder cancer	0.000269	0.000813	CcSEcCtD
Fluconazole—Diarrhoea—Cisplatin—urinary bladder cancer	0.000266	0.000803	CcSEcCtD
Fluconazole—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000266	0.000802	CcSEcCtD
Fluconazole—Alopecia—Methotrexate—urinary bladder cancer	0.000265	0.000801	CcSEcCtD
Fluconazole—Vomiting—Gemcitabine—urinary bladder cancer	0.000265	0.000801	CcSEcCtD
Fluconazole—Mental disorder—Methotrexate—urinary bladder cancer	0.000263	0.000794	CcSEcCtD
Fluconazole—Rash—Gemcitabine—urinary bladder cancer	0.000263	0.000794	CcSEcCtD
Fluconazole—Dermatitis—Gemcitabine—urinary bladder cancer	0.000263	0.000793	CcSEcCtD
Fluconazole—Eye disorder—Epirubicin—urinary bladder cancer	0.000263	0.000793	CcSEcCtD
Fluconazole—Hypersensitivity—Etoposide—urinary bladder cancer	0.000262	0.000792	CcSEcCtD
Fluconazole—Malnutrition—Methotrexate—urinary bladder cancer	0.000261	0.000789	CcSEcCtD
Fluconazole—Headache—Gemcitabine—urinary bladder cancer	0.000261	0.000789	CcSEcCtD
Fluconazole—Flushing—Epirubicin—urinary bladder cancer	0.000261	0.000787	CcSEcCtD
Fluconazole—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000261	0.000787	CcSEcCtD
Fluconazole—Vomiting—Fluorouracil—urinary bladder cancer	0.000261	0.000787	CcSEcCtD
Fluconazole—Rash—Fluorouracil—urinary bladder cancer	0.000258	0.000781	CcSEcCtD
Fluconazole—Dermatitis—Fluorouracil—urinary bladder cancer	0.000258	0.00078	CcSEcCtD
Fluconazole—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000258	0.000779	CcSEcCtD
Fluconazole—Headache—Fluorouracil—urinary bladder cancer	0.000257	0.000776	CcSEcCtD
Fluconazole—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000257	0.000775	CcSEcCtD
Fluconazole—Dysgeusia—Methotrexate—urinary bladder cancer	0.000256	0.000773	CcSEcCtD
Fluconazole—Asthenia—Etoposide—urinary bladder cancer	0.000255	0.000771	CcSEcCtD
Fluconazole—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000255	0.000771	CcSEcCtD
Fluconazole—Angiopathy—Epirubicin—urinary bladder cancer	0.000255	0.00077	CcSEcCtD
Fluconazole—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000255	0.000769	CcSEcCtD
Fluconazole—Immune system disorder—Epirubicin—urinary bladder cancer	0.000254	0.000766	CcSEcCtD
Fluconazole—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000253	0.000765	CcSEcCtD
Fluconazole—Back pain—Methotrexate—urinary bladder cancer	0.000253	0.000763	CcSEcCtD
Fluconazole—Chills—Epirubicin—urinary bladder cancer	0.000252	0.000761	CcSEcCtD
Fluconazole—Pruritus—Etoposide—urinary bladder cancer	0.000252	0.000761	CcSEcCtD
Fluconazole—Visual impairment—Doxorubicin—urinary bladder cancer	0.00025	0.000756	CcSEcCtD
Fluconazole—Alopecia—Epirubicin—urinary bladder cancer	0.000248	0.00075	CcSEcCtD
Fluconazole—Nausea—Gemcitabine—urinary bladder cancer	0.000248	0.000748	CcSEcCtD
Fluconazole—Vomiting—Cisplatin—urinary bladder cancer	0.000247	0.000746	CcSEcCtD
Fluconazole—Mental disorder—Epirubicin—urinary bladder cancer	0.000246	0.000743	CcSEcCtD
Fluconazole—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000246	0.000742	CcSEcCtD
Fluconazole—Rash—Cisplatin—urinary bladder cancer	0.000245	0.00074	CcSEcCtD
Fluconazole—Dermatitis—Cisplatin—urinary bladder cancer	0.000245	0.000739	CcSEcCtD
Fluconazole—Malnutrition—Epirubicin—urinary bladder cancer	0.000245	0.000738	CcSEcCtD
Fluconazole—Diarrhoea—Etoposide—urinary bladder cancer	0.000244	0.000736	CcSEcCtD
Fluconazole—Nausea—Fluorouracil—urinary bladder cancer	0.000244	0.000735	CcSEcCtD
Fluconazole—Eye disorder—Doxorubicin—urinary bladder cancer	0.000243	0.000734	CcSEcCtD
Fluconazole—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000242	0.000732	CcSEcCtD
Fluconazole—Anaemia—Methotrexate—urinary bladder cancer	0.000242	0.000729	CcSEcCtD
Fluconazole—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000241	0.000728	CcSEcCtD
Fluconazole—Flushing—Doxorubicin—urinary bladder cancer	0.000241	0.000728	CcSEcCtD
Fluconazole—Flatulence—Epirubicin—urinary bladder cancer	0.000241	0.000728	CcSEcCtD
Fluconazole—Tension—Epirubicin—urinary bladder cancer	0.00024	0.000725	CcSEcCtD
Fluconazole—Dysgeusia—Epirubicin—urinary bladder cancer	0.000239	0.000723	CcSEcCtD
Fluconazole—Nervousness—Epirubicin—urinary bladder cancer	0.000238	0.000717	CcSEcCtD
Fluconazole—Back pain—Epirubicin—urinary bladder cancer	0.000237	0.000714	CcSEcCtD
Fluconazole—Angiopathy—Doxorubicin—urinary bladder cancer	0.000236	0.000712	CcSEcCtD
Fluconazole—Malaise—Methotrexate—urinary bladder cancer	0.000236	0.000712	CcSEcCtD
Fluconazole—Dizziness—Etoposide—urinary bladder cancer	0.000235	0.000711	CcSEcCtD
Fluconazole—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000235	0.000709	CcSEcCtD
Fluconazole—Vertigo—Methotrexate—urinary bladder cancer	0.000235	0.000709	CcSEcCtD
Fluconazole—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000234	0.000707	CcSEcCtD
Fluconazole—Leukopenia—Methotrexate—urinary bladder cancer	0.000234	0.000706	CcSEcCtD
Fluconazole—Chills—Doxorubicin—urinary bladder cancer	0.000233	0.000704	CcSEcCtD
Fluconazole—Nausea—Cisplatin—urinary bladder cancer	0.000231	0.000697	CcSEcCtD
Fluconazole—Alopecia—Doxorubicin—urinary bladder cancer	0.00023	0.000694	CcSEcCtD
Fluconazole—Mental disorder—Doxorubicin—urinary bladder cancer	0.000228	0.000688	CcSEcCtD
Fluconazole—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000227	0.000685	CcSEcCtD
Fluconazole—Convulsion—Methotrexate—urinary bladder cancer	0.000226	0.000684	CcSEcCtD
Fluconazole—Vomiting—Etoposide—urinary bladder cancer	0.000226	0.000684	CcSEcCtD
Fluconazole—Malnutrition—Doxorubicin—urinary bladder cancer	0.000226	0.000683	CcSEcCtD
Fluconazole—Anaemia—Epirubicin—urinary bladder cancer	0.000226	0.000683	CcSEcCtD
Fluconazole—Agitation—Epirubicin—urinary bladder cancer	0.000225	0.000679	CcSEcCtD
Fluconazole—Rash—Etoposide—urinary bladder cancer	0.000225	0.000678	CcSEcCtD
Fluconazole—Dermatitis—Etoposide—urinary bladder cancer	0.000224	0.000677	CcSEcCtD
Fluconazole—Headache—Etoposide—urinary bladder cancer	0.000223	0.000674	CcSEcCtD
Fluconazole—Flatulence—Doxorubicin—urinary bladder cancer	0.000223	0.000673	CcSEcCtD
Fluconazole—Myalgia—Methotrexate—urinary bladder cancer	0.000222	0.000672	CcSEcCtD
Fluconazole—Tension—Doxorubicin—urinary bladder cancer	0.000222	0.000671	CcSEcCtD
Fluconazole—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000222	0.000669	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000221	0.000667	CcSEcCtD
Fluconazole—Malaise—Epirubicin—urinary bladder cancer	0.000221	0.000666	CcSEcCtD
Fluconazole—Discomfort—Methotrexate—urinary bladder cancer	0.00022	0.000664	CcSEcCtD
Fluconazole—Nervousness—Doxorubicin—urinary bladder cancer	0.00022	0.000664	CcSEcCtD
Fluconazole—Vertigo—Epirubicin—urinary bladder cancer	0.00022	0.000663	CcSEcCtD
Fluconazole—Leukopenia—Epirubicin—urinary bladder cancer	0.000219	0.000661	CcSEcCtD
Fluconazole—Back pain—Doxorubicin—urinary bladder cancer	0.000219	0.000661	CcSEcCtD
Fluconazole—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000213	0.000644	CcSEcCtD
Fluconazole—Convulsion—Epirubicin—urinary bladder cancer	0.000212	0.00064	CcSEcCtD
Fluconazole—Nausea—Etoposide—urinary bladder cancer	0.000211	0.000639	CcSEcCtD
Fluconazole—Hypertension—Epirubicin—urinary bladder cancer	0.000211	0.000638	CcSEcCtD
Fluconazole—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.00021	0.000634	CcSEcCtD
Fluconazole—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000209	0.000632	CcSEcCtD
Fluconazole—Anaemia—Doxorubicin—urinary bladder cancer	0.000209	0.000632	CcSEcCtD
Fluconazole—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000209	0.000631	CcSEcCtD
Fluconazole—Myalgia—Epirubicin—urinary bladder cancer	0.000208	0.000629	CcSEcCtD
Fluconazole—Agitation—Doxorubicin—urinary bladder cancer	0.000208	0.000628	CcSEcCtD
Fluconazole—Skin disorder—Methotrexate—urinary bladder cancer	0.000207	0.000626	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000207	0.000624	CcSEcCtD
Fluconazole—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000206	0.000623	CcSEcCtD
Fluconazole—Discomfort—Epirubicin—urinary bladder cancer	0.000206	0.000621	CcSEcCtD
Fluconazole—Malaise—Doxorubicin—urinary bladder cancer	0.000204	0.000616	CcSEcCtD
Fluconazole—Dry mouth—Epirubicin—urinary bladder cancer	0.000204	0.000615	CcSEcCtD
Fluconazole—Vertigo—Doxorubicin—urinary bladder cancer	0.000203	0.000614	CcSEcCtD
Fluconazole—Anorexia—Methotrexate—urinary bladder cancer	0.000203	0.000614	CcSEcCtD
Fluconazole—Leukopenia—Doxorubicin—urinary bladder cancer	0.000203	0.000612	CcSEcCtD
Fluconazole—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.0002	0.000603	CcSEcCtD
Fluconazole—Convulsion—Doxorubicin—urinary bladder cancer	0.000196	0.000592	CcSEcCtD
Fluconazole—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000196	0.000591	CcSEcCtD
Fluconazole—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000195	0.00059	CcSEcCtD
Fluconazole—Hypertension—Doxorubicin—urinary bladder cancer	0.000195	0.00059	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000194	0.000587	CcSEcCtD
Fluconazole—Skin disorder—Epirubicin—urinary bladder cancer	0.000194	0.000585	CcSEcCtD
Fluconazole—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000193	0.000583	CcSEcCtD
Fluconazole—Insomnia—Methotrexate—urinary bladder cancer	0.000193	0.000583	CcSEcCtD
Fluconazole—Myalgia—Doxorubicin—urinary bladder cancer	0.000193	0.000582	CcSEcCtD
Fluconazole—Paraesthesia—Methotrexate—urinary bladder cancer	0.000192	0.000578	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000191	0.000578	CcSEcCtD
Fluconazole—Discomfort—Doxorubicin—urinary bladder cancer	0.00019	0.000575	CcSEcCtD
Fluconazole—Anorexia—Epirubicin—urinary bladder cancer	0.00019	0.000575	CcSEcCtD
Fluconazole—Somnolence—Methotrexate—urinary bladder cancer	0.00019	0.000573	CcSEcCtD
Fluconazole—Dry mouth—Doxorubicin—urinary bladder cancer	0.000188	0.000569	CcSEcCtD
Fluconazole—Dyspepsia—Methotrexate—urinary bladder cancer	0.000188	0.000567	CcSEcCtD
Fluconazole—Decreased appetite—Methotrexate—urinary bladder cancer	0.000185	0.00056	CcSEcCtD
Fluconazole—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000185	0.000558	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000184	0.000556	CcSEcCtD
Fluconazole—Fatigue—Methotrexate—urinary bladder cancer	0.000184	0.000555	CcSEcCtD
Fluconazole—Pain—Methotrexate—urinary bladder cancer	0.000182	0.000551	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000182	0.000549	CcSEcCtD
Fluconazole—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000181	0.000547	CcSEcCtD
Fluconazole—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000181	0.000546	CcSEcCtD
Fluconazole—Insomnia—Epirubicin—urinary bladder cancer	0.000181	0.000545	CcSEcCtD
Fluconazole—Skin disorder—Doxorubicin—urinary bladder cancer	0.000179	0.000542	CcSEcCtD
Fluconazole—Paraesthesia—Epirubicin—urinary bladder cancer	0.000179	0.000541	CcSEcCtD
Fluconazole—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000179	0.000539	CcSEcCtD
Fluconazole—Somnolence—Epirubicin—urinary bladder cancer	0.000177	0.000536	CcSEcCtD
Fluconazole—Anorexia—Doxorubicin—urinary bladder cancer	0.000176	0.000532	CcSEcCtD
Fluconazole—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000176	0.000531	CcSEcCtD
Fluconazole—Dyspepsia—Epirubicin—urinary bladder cancer	0.000176	0.000531	CcSEcCtD
Fluconazole—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000174	0.000527	CcSEcCtD
Fluconazole—Decreased appetite—Epirubicin—urinary bladder cancer	0.000174	0.000524	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000172	0.00052	CcSEcCtD
Fluconazole—Fatigue—Epirubicin—urinary bladder cancer	0.000172	0.00052	CcSEcCtD
Fluconazole—Pain—Epirubicin—urinary bladder cancer	0.000171	0.000515	CcSEcCtD
Fluconazole—Constipation—Epirubicin—urinary bladder cancer	0.000171	0.000515	CcSEcCtD
Fluconazole—Urticaria—Methotrexate—urinary bladder cancer	0.000169	0.000512	CcSEcCtD
Fluconazole—Abdominal pain—Methotrexate—urinary bladder cancer	0.000169	0.000509	CcSEcCtD
Fluconazole—Body temperature increased—Methotrexate—urinary bladder cancer	0.000169	0.000509	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000168	0.000508	CcSEcCtD
Fluconazole—Insomnia—Doxorubicin—urinary bladder cancer	0.000167	0.000504	CcSEcCtD
Fluconazole—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000166	0.000501	CcSEcCtD
Fluconazole—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000164	0.000497	CcSEcCtD
Fluconazole—Somnolence—Doxorubicin—urinary bladder cancer	0.000164	0.000496	CcSEcCtD
Fluconazole—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000163	0.000493	CcSEcCtD
Fluconazole—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000163	0.000491	CcSEcCtD
Fluconazole—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000161	0.000485	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000159	0.000481	CcSEcCtD
Fluconazole—Fatigue—Doxorubicin—urinary bladder cancer	0.000159	0.000481	CcSEcCtD
Fluconazole—Urticaria—Epirubicin—urinary bladder cancer	0.000159	0.000479	CcSEcCtD
Fluconazole—Pain—Doxorubicin—urinary bladder cancer	0.000158	0.000477	CcSEcCtD
Fluconazole—Constipation—Doxorubicin—urinary bladder cancer	0.000158	0.000477	CcSEcCtD
Fluconazole—Abdominal pain—Epirubicin—urinary bladder cancer	0.000158	0.000476	CcSEcCtD
Fluconazole—Body temperature increased—Epirubicin—urinary bladder cancer	0.000158	0.000476	CcSEcCtD
Fluconazole—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000157	0.000475	CcSEcCtD
Fluconazole—CYP11B1—Metabolism—TYMP—urinary bladder cancer	0.000157	0.00124	CbGpPWpGaD
Fluconazole—CYP3A5—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000156	0.00124	CbGpPWpGaD
Fluconazole—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000156	0.00123	CbGpPWpGaD
Fluconazole—Asthenia—Methotrexate—urinary bladder cancer	0.000153	0.000462	CcSEcCtD
Fluconazole—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000152	0.00046	CcSEcCtD
Fluconazole—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000151	0.000456	CcSEcCtD
Fluconazole—Pruritus—Methotrexate—urinary bladder cancer	0.000151	0.000456	CcSEcCtD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000151	0.00119	CbGpPWpGaD
Fluconazole—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000148	0.00117	CbGpPWpGaD
Fluconazole—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000147	0.000444	CcSEcCtD
Fluconazole—Urticaria—Doxorubicin—urinary bladder cancer	0.000147	0.000443	CcSEcCtD
Fluconazole—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000146	0.000441	CcSEcCtD
Fluconazole—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000146	0.000441	CcSEcCtD
Fluconazole—Diarrhoea—Methotrexate—urinary bladder cancer	0.000146	0.000441	CcSEcCtD
Fluconazole—CYP3A5—Biological oxidations—GSTM1—urinary bladder cancer	0.000146	0.00115	CbGpPWpGaD
Fluconazole—CYP3A5—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000144	0.00114	CbGpPWpGaD
Fluconazole—Asthenia—Epirubicin—urinary bladder cancer	0.000143	0.000432	CcSEcCtD
Fluconazole—CYP11B1—Metabolism—NAT2—urinary bladder cancer	0.000142	0.00112	CbGpPWpGaD
Fluconazole—Pruritus—Epirubicin—urinary bladder cancer	0.000141	0.000426	CcSEcCtD
Fluconazole—Dizziness—Methotrexate—urinary bladder cancer	0.000141	0.000426	CcSEcCtD
Fluconazole—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000137	0.00108	CbGpPWpGaD
Fluconazole—Diarrhoea—Epirubicin—urinary bladder cancer	0.000137	0.000412	CcSEcCtD
Fluconazole—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000136	0.000411	CcSEcCtD
Fluconazole—Vomiting—Methotrexate—urinary bladder cancer	0.000136	0.000409	CcSEcCtD
Fluconazole—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000135	0.00107	CbGpPWpGaD
Fluconazole—Rash—Methotrexate—urinary bladder cancer	0.000134	0.000406	CcSEcCtD
Fluconazole—Dermatitis—Methotrexate—urinary bladder cancer	0.000134	0.000406	CcSEcCtD
Fluconazole—CYP3A7—Metabolism—GSTZ1—urinary bladder cancer	0.000134	0.00106	CbGpPWpGaD
Fluconazole—Headache—Methotrexate—urinary bladder cancer	0.000134	0.000403	CcSEcCtD
Fluconazole—Asthenia—Doxorubicin—urinary bladder cancer	0.000132	0.0004	CcSEcCtD
Fluconazole—Dizziness—Epirubicin—urinary bladder cancer	0.000132	0.000399	CcSEcCtD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000132	0.00104	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000131	0.00103	CbGpPWpGaD
Fluconazole—Pruritus—Doxorubicin—urinary bladder cancer	0.000131	0.000395	CcSEcCtD
Fluconazole—CYP3A7—Metabolism—GSTO2—urinary bladder cancer	0.000127	0.00101	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—NAT1—urinary bladder cancer	0.000127	0.00101	CbGpPWpGaD
Fluconazole—Vomiting—Epirubicin—urinary bladder cancer	0.000127	0.000383	CcSEcCtD
Fluconazole—Nausea—Methotrexate—urinary bladder cancer	0.000127	0.000383	CcSEcCtD
Fluconazole—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000126	0.000382	CcSEcCtD
Fluconazole—Rash—Epirubicin—urinary bladder cancer	0.000126	0.00038	CcSEcCtD
Fluconazole—Dermatitis—Epirubicin—urinary bladder cancer	0.000126	0.00038	CcSEcCtD
Fluconazole—Headache—Epirubicin—urinary bladder cancer	0.000125	0.000378	CcSEcCtD
Fluconazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	0.000123	0.000969	CbGpPWpGaD
Fluconazole—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	0.000123	0.000969	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—RRM2—urinary bladder cancer	0.000122	0.000967	CbGpPWpGaD
Fluconazole—Dizziness—Doxorubicin—urinary bladder cancer	0.000122	0.000369	CcSEcCtD
Fluconazole—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000121	0.000955	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00012	0.000948	CbGpPWpGaD
Fluconazole—Nausea—Epirubicin—urinary bladder cancer	0.000119	0.000358	CcSEcCtD
Fluconazole—Vomiting—Doxorubicin—urinary bladder cancer	0.000117	0.000355	CcSEcCtD
Fluconazole—CYP3A7—Metabolism—UGT2B7—urinary bladder cancer	0.000116	0.000921	CbGpPWpGaD
Fluconazole—Rash—Doxorubicin—urinary bladder cancer	0.000116	0.000352	CcSEcCtD
Fluconazole—Dermatitis—Doxorubicin—urinary bladder cancer	0.000116	0.000351	CcSEcCtD
Fluconazole—Headache—Doxorubicin—urinary bladder cancer	0.000116	0.000349	CcSEcCtD
Fluconazole—CYP11B1—Metabolism—HPGDS—urinary bladder cancer	0.000113	0.000896	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—ENO2—urinary bladder cancer	0.000113	0.000896	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000113	0.000891	CbGpPWpGaD
Fluconazole—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	0.000113	0.00089	CbGpPWpGaD
Fluconazole—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	0.000112	0.000885	CbGpPWpGaD
Fluconazole—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	0.000112	0.000883	CbGpPWpGaD
Fluconazole—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000111	0.000878	CbGpPWpGaD
Fluconazole—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	0.000111	0.000876	CbGpPWpGaD
Fluconazole—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00011	0.000871	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—GSTT1—urinary bladder cancer	0.00011	0.000869	CbGpPWpGaD
Fluconazole—Nausea—Doxorubicin—urinary bladder cancer	0.00011	0.000331	CcSEcCtD
Fluconazole—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.00011	0.000866	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000108	0.000856	CbGpPWpGaD
Fluconazole—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000107	0.000847	CbGpPWpGaD
Fluconazole—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	0.000107	0.000846	CbGpPWpGaD
Fluconazole—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000106	0.00084	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—CYP4B1—urinary bladder cancer	0.000105	0.000829	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000104	0.000823	CbGpPWpGaD
Fluconazole—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	0.000103	0.000812	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000102	0.000808	CbGpPWpGaD
Fluconazole—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000101	0.0008	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—SLC19A1—urinary bladder cancer	9.9e-05	0.000783	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	9.71e-05	0.000767	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—PRSS3—urinary bladder cancer	9.65e-05	0.000763	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	9.21e-05	0.000728	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—NAT1—urinary bladder cancer	9.21e-05	0.000728	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—NQO1—urinary bladder cancer	9.14e-05	0.000722	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	9.06e-05	0.000716	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.87e-05	0.000701	CbGpPWpGaD
Fluconazole—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	8.74e-05	0.000691	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	8.42e-05	0.000665	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	8.01e-05	0.000633	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	7.97e-05	0.00063	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	7.94e-05	0.000628	CbGpPWpGaD
Fluconazole—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	7.8e-05	0.000616	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.73e-05	0.000611	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—TYMP—urinary bladder cancer	7.72e-05	0.00061	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—GSTP1—urinary bladder cancer	7.62e-05	0.000602	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	7.58e-05	0.000599	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	7.51e-05	0.000593	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.37e-05	0.000583	CbGpPWpGaD
Fluconazole—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	7.37e-05	0.000582	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	7.33e-05	0.000579	CbGpPWpGaD
Fluconazole—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	7.27e-05	0.000574	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	7.16e-05	0.000566	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	7.12e-05	0.000562	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—NAT1—urinary bladder cancer	7.12e-05	0.000562	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—TYMS—urinary bladder cancer	7.08e-05	0.00056	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—NCOR1—urinary bladder cancer	7e-05	0.000553	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—GSTM1—urinary bladder cancer	7e-05	0.000553	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	7e-05	0.000553	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—NAT2—urinary bladder cancer	6.98e-05	0.000551	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	6.98e-05	0.000551	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	6.96e-05	0.00055	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GSTO2—urinary bladder cancer	6.95e-05	0.000549	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—NAT1—urinary bladder cancer	6.95e-05	0.000549	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	6.87e-05	0.000543	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	6.85e-05	0.000541	CbGpPWpGaD
Fluconazole—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	6.77e-05	0.000535	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—GPX1—urinary bladder cancer	6.71e-05	0.00053	CbGpPWpGaD
Fluconazole—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.68e-05	0.000528	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—ERCC2—urinary bladder cancer	6.58e-05	0.00052	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	6.51e-05	0.000514	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	6.49e-05	0.000513	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—NAT1—urinary bladder cancer	6.49e-05	0.000513	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.38e-05	0.000504	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	6.35e-05	0.000502	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—MTHFR—urinary bladder cancer	6.19e-05	0.000489	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—RRM2—urinary bladder cancer	6.02e-05	0.000476	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	5.94e-05	0.000469	CbGpPWpGaD
Fluconazole—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.9e-05	0.000467	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	5.86e-05	0.000463	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	5.83e-05	0.000461	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	5.72e-05	0.000452	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	5.7e-05	0.00045	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—ENO2—urinary bladder cancer	5.58e-05	0.000441	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	5.58e-05	0.000441	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—TYMP—urinary bladder cancer	5.58e-05	0.000441	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	5.53e-05	0.000437	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	5.41e-05	0.000428	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	5.4e-05	0.000427	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	5.39e-05	0.000426	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	5.34e-05	0.000422	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—PRSS3—urinary bladder cancer	5.26e-05	0.000416	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	5.15e-05	0.000407	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	5.05e-05	0.000399	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—NAT2—urinary bladder cancer	5.04e-05	0.000399	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—PPARG—urinary bladder cancer	5.02e-05	0.000397	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	4.98e-05	0.000394	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	4.97e-05	0.000393	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	4.92e-05	0.000389	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—CREBBP—urinary bladder cancer	4.82e-05	0.000381	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	4.74e-05	0.000375	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	4.61e-05	0.000364	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	4.51e-05	0.000357	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—NQO1—urinary bladder cancer	4.5e-05	0.000355	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—RRM2—urinary bladder cancer	4.35e-05	0.000344	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.32e-05	0.000342	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—TYMP—urinary bladder cancer	4.31e-05	0.000341	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	4.28e-05	0.000338	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—NAT1—urinary bladder cancer	4.28e-05	0.000338	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—TYMP—urinary bladder cancer	4.21e-05	0.000333	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.14e-05	0.000327	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	4.13e-05	0.000326	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	4.04e-05	0.000319	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	4.03e-05	0.000319	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—ENO2—urinary bladder cancer	4.03e-05	0.000319	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—PTGS2—urinary bladder cancer	3.95e-05	0.000312	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.94e-05	0.000312	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—TYMP—urinary bladder cancer	3.93e-05	0.000311	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.91e-05	0.000309	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	3.91e-05	0.000309	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—NAT2—urinary bladder cancer	3.9e-05	0.000308	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.85e-05	0.000304	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.82e-05	0.000302	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—NAT2—urinary bladder cancer	3.81e-05	0.000301	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.78e-05	0.000298	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	3.75e-05	0.000296	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—NAT2—urinary bladder cancer	3.56e-05	0.000281	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.52e-05	0.000279	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—TYMS—urinary bladder cancer	3.49e-05	0.000276	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	3.45e-05	0.000272	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	3.45e-05	0.000272	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—PTEN—urinary bladder cancer	3.44e-05	0.000272	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.39e-05	0.000268	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—RRM2—urinary bladder cancer	3.37e-05	0.000266	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.33e-05	0.000263	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—GPX1—urinary bladder cancer	3.3e-05	0.000261	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—RRM2—urinary bladder cancer	3.29e-05	0.00026	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—EP300—urinary bladder cancer	3.28e-05	0.00026	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—NQO1—urinary bladder cancer	3.25e-05	0.000257	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.24e-05	0.000256	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	3.24e-05	0.000256	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	3.12e-05	0.000246	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—ENO2—urinary bladder cancer	3.12e-05	0.000246	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.1e-05	0.000245	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—RRM2—urinary bladder cancer	3.07e-05	0.000243	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	3.05e-05	0.000241	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—HPGDS—urinary bladder cancer	3.04e-05	0.00024	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—ENO2—urinary bladder cancer	3.04e-05	0.00024	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	3.02e-05	0.000239	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.98e-05	0.000235	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2.95e-05	0.000233	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—ENO2—urinary bladder cancer	2.84e-05	0.000225	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	2.84e-05	0.000225	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.83e-05	0.000223	CbGpPWpGaD
Fluconazole—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.76e-05	0.000218	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	2.76e-05	0.000218	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.71e-05	0.000215	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	2.71e-05	0.000214	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—TYMS—urinary bladder cancer	2.52e-05	0.000199	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—NQO1—urinary bladder cancer	2.51e-05	0.000199	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	2.49e-05	0.000197	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	2.49e-05	0.000197	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—PPARG—urinary bladder cancer	2.47e-05	0.000195	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.45e-05	0.000194	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.44e-05	0.000193	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GPX1—urinary bladder cancer	2.39e-05	0.000189	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	2.37e-05	0.000188	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.34e-05	0.000185	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	2.34e-05	0.000185	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—NQO1—urinary bladder cancer	2.29e-05	0.000181	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.22e-05	0.000176	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	2.2e-05	0.000174	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.13e-05	0.000168	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	2.1e-05	0.000166	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GSTP1—urinary bladder cancer	2.05e-05	0.000162	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.03e-05	0.00016	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.02e-05	0.00016	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.95e-05	0.000154	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	1.94e-05	0.000154	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.94e-05	0.000153	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.93e-05	0.000152	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.93e-05	0.000152	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.91e-05	0.000151	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.9e-05	0.00015	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.88e-05	0.000149	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.88e-05	0.000149	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.87e-05	0.000148	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.87e-05	0.000148	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.85e-05	0.000146	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.84e-05	0.000146	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.82e-05	0.000144	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.81e-05	0.000143	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.8e-05	0.000142	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—PPARG—urinary bladder cancer	1.79e-05	0.000141	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.78e-05	0.00014	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.77e-05	0.00014	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.76e-05	0.000139	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.76e-05	0.000139	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	1.72e-05	0.000136	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.7e-05	0.000135	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—PTEN—urinary bladder cancer	1.69e-05	0.000134	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.68e-05	0.000133	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.66e-05	0.000131	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.65e-05	0.00013	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—EP300—urinary bladder cancer	1.62e-05	0.000128	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.55e-05	0.000123	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.51e-05	0.000119	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	1.4e-05	0.000111	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.38e-05	0.000109	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.35e-05	0.000106	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.33e-05	0.000105	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.29e-05	0.000102	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.26e-05	9.96e-05	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.26e-05	9.95e-05	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—PTEN—urinary bladder cancer	1.22e-05	9.68e-05	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.21e-05	9.55e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.17e-05	9.26e-05	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—EP300—urinary bladder cancer	1.17e-05	9.23e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.16e-05	9.15e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.16e-05	9.15e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.11e-05	8.77e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.09e-05	8.61e-05	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.09e-05	8.58e-05	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.06e-05	8.38e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.02e-05	8.09e-05	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	9.9e-06	7.82e-05	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—PTEN—urinary bladder cancer	9.47e-06	7.48e-05	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—PTEN—urinary bladder cancer	9.24e-06	7.3e-05	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—EP300—urinary bladder cancer	9.03e-06	7.14e-05	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—EP300—urinary bladder cancer	8.81e-06	6.97e-05	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—PTEN—urinary bladder cancer	8.63e-06	6.82e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—PPARG—urinary bladder cancer	8.3e-06	6.56e-05	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—EP300—urinary bladder cancer	8.23e-06	6.51e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	7.97e-06	6.3e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	6.53e-06	5.16e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—PTEN—urinary bladder cancer	5.69e-06	4.5e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—EP300—urinary bladder cancer	5.43e-06	4.29e-05	CbGpPWpGaD
